UK Markets closed

Apontis Pharma AG (APPH.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
10.65-0.30 (-2.74%)
At close: 09:09AM CEST
Full screen
Previous close10.95
Open10.65
Bid10.30 x N/A
Ask11.45 x N/A
Day's range10.65 - 10.65
52-week range10.40 - 27.30
Volume180
Avg. volume157
Market cap90.525M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.17
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est29.00
  • EQS Group

    APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052

    DGAP-News: APONTIS PHARMA AG / Key word(s): Share BuybackAPONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052 23.06.2022 / 07:30 The issuer is solely responsible for the content of this announcement.APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052Monheim am Rhein, 23 June 2022. APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5), a leading pharmaceutical company specializing in Single Pills in the G

  • EQS Group

    APONTIS PHARMA launches two new single pills - medium-term revenue potential of EUR 8.2 million

    DGAP-News: APONTIS PHARMA AG / Key word(s): Product LaunchAPONTIS PHARMA launches two new single pills - medium-term revenue potential of EUR 8.2 million 25.05.2022 / 07:30 The issuer is solely responsible for the content of this announcement.APONTIS PHARMA launches two new single pills - medium-term revenue potential of EUR 8.2 million Medium-term revenue potential of Tonotec Lipid: EUR 5.0 million Medium-term revenue potential of AmloAtor: EUR 3.2 million Potential patient group of 750,000 peo

  • EQS Group

    APONTIS PHARMA holds Annual General Meeting 2022 - shareholders approve all agenda items with large majorities

    DGAP-News: APONTIS PHARMA AG / Key word(s): AGM/EGMAPONTIS PHARMA holds Annual General Meeting 2022 - shareholders approve all agenda items with large majorities 12.05.2022 / 15:00 The issuer is solely responsible for the content of this announcement.APONTIS PHARMA holds Annual General Meeting 2022 - shareholders approve all agenda items with large majoritiesMonheim am Rhein, 12 May 2022. APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5), a leading pharmaceutical company specializing in Single